Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | YTB323 |
Trade Name | |
Synonyms | YTB-323|YTB 323|CD19-specific CAR T cells YTB323 |
Drug Descriptions |
YTB323 are autologous T cells that express a chimeric antigen receptor (CAR) targeting CD19, potentially resulting in cytotoxicity against CD19-expressing tumor cells (PMID: 37249512). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | C175534 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ibrutinib + YTB323 | Ibrutinib YTB323 | 0 | 1 |
YTB323 | YTB323 | 0 | 1 |